PubMed:7694465 / 376-648 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T5","span":{"begin":0,"end":272},"obj":"Sentence"},{"id":"T5","span":{"begin":0,"end":272},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We hypothesized that increased endothelial cell release or decreased proteolytic degradation of insulin-like growth factor-binding protein-3 in preeclampsia would result in higher circulating levels of insulin-like growth factors and hence in increased mitogenic activity."}

{"project":"Preeclampsia","denotations":[{"id":"PD-Preeclampsia-B_T3","span":{"begin":144,"end":156},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"We hypothesized that increased endothelial cell release or decreased proteolytic degradation of insulin-like growth factor-binding protein-3 in preeclampsia would result in higher circulating levels of insulin-like growth factors and hence in increased mitogenic activity."}

{"project":"Preeclampsia-compare","denotations":[{"id":"PD-Preeclampsia-B_T3","span":{"begin":144,"end":156},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"We hypothesized that increased endothelial cell release or decreased proteolytic degradation of insulin-like growth factor-binding protein-3 in preeclampsia would result in higher circulating levels of insulin-like growth factors and hence in increased mitogenic activity."}

{"project":"preeclampsia_genes","denotations":[{"id":"PD-PreeclampsiaGenes-B_T3","span":{"begin":96,"end":103},"obj":"HGNC:INS"},{"id":"PD-PreeclampsiaGenes-B_T4","span":{"begin":202,"end":209},"obj":"HGNC:INS"},{"id":"PD-PreeclampsiaGenes-B_T12","span":{"begin":96,"end":122},"obj":"HGNC:IGF2"},{"id":"PD-PreeclampsiaGenes-B_T13","span":{"begin":202,"end":229},"obj":"HGNC:IGF2"},{"id":"PD-PreeclampsiaGenes-B_T21","span":{"begin":96,"end":122},"obj":"HGNC:IGF1"},{"id":"PD-PreeclampsiaGenes-B_T22","span":{"begin":202,"end":229},"obj":"HGNC:IGF1"},{"id":"PD-PreeclampsiaGenes-B_T30","span":{"begin":96,"end":138},"obj":"HGNC:IGFBP7"},{"id":"PD-PreeclampsiaGenes-B_T37","span":{"begin":96,"end":140},"obj":"HGNC:IGFBP3"},{"id":"PD-PreeclampsiaGenes-B_T44","span":{"begin":96,"end":138},"obj":"HGNC:IGFBP2"},{"id":"PD-PreeclampsiaGenes-B_T51","span":{"begin":96,"end":138},"obj":"HGNC:IGFBP4"},{"id":"PD-PreeclampsiaGenes-B_T58","span":{"begin":96,"end":138},"obj":"HGNC:IGFBP5"}],"text":"We hypothesized that increased endothelial cell release or decreased proteolytic degradation of insulin-like growth factor-binding protein-3 in preeclampsia would result in higher circulating levels of insulin-like growth factors and hence in increased mitogenic activity."}